World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
58
Citations
10712
World Ranking
10743
National Ranking
2956

John L. Neumeyer publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where John L. Neumeyer sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 315 publications — 66th percentile

66% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

John L. Neumeyer D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where John L. Neumeyer sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 58 D-Index — 42nd percentile

42% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Research.com Recognitions

  • 2011 - Fellow of the American Chemical Society
  • 1984 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Organic chemistry
  • Dopamine
  • Biochemistry

John L. Neumeyer mainly investigates Dopamine, Stereochemistry, Internal medicine, Endocrinology and Receptor. His Dopamine research integrates issues from Monoamine neurotransmitter, Serotonin, Neurotransmitter and Tropane. John L. Neumeyer has included themes like Ligand binding assay, GTPgammaS and Binding site in his Stereochemistry study.

In his study, Washout and Basal ganglia is inextricably linked to Human brain, which falls within the broad field of Internal medicine. The Globus pallidus research John L. Neumeyer does as part of his general Endocrinology study is frequently linked to other disciplines of science, such as Biting, therefore creating a link between diverse domains of science. His Receptor research includes elements of Substituent and Selectivity.

His most cited work include:

  • SPECT imaging of dopamine and serotonin transporters with [123I]β‐CIT: Pharmacological characterization of brain uptake in nonhuman primates (335 citations)
  • Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects (264 citations)
  • Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders (260 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Stereochemistry, Dopamine, Pharmacology, Receptor and Dopamine receptor. His research integrates issues of Chemical synthesis and Binding site in his study of Stereochemistry. His Dopamine research is multidisciplinary, incorporating perspectives in Tropane and Serotonin.

His research investigates the connection between Tropane and topics such as Dopamine transporter that intersect with problems in Nuclear medicine. His Pharmacology study combines topics from a wide range of disciplines, such as Spiperone, Dopamine antagonist and Dopamine agonist. His studies in Dopamine receptor integrate themes in fields like Dopaminergic and Nucleus accumbens.

He most often published in these fields:

  • Stereochemistry (44.24%)
  • Dopamine (32.12%)
  • Pharmacology (23.94%)

What were the highlights of his more recent work (between 2003-2021)?

  • Stereochemistry (44.24%)
  • Receptor (25.15%)
  • Agonist (19.09%)

In recent papers he was focusing on the following fields of study:

Stereochemistry, Receptor, Agonist, Pharmacology and Dopamine are his primary areas of study. His biological study spans a wide range of topics, including Opioid receptor, Chemical synthesis and Ligand. The study incorporates disciplines such as Structure–activity relationship, Aporphines and Aporphine in addition to Receptor.

As a part of the same scientific family, he mostly works in the field of Agonist, focusing on Dopamine receptor D2 and, on occasion, Dopaminergic and Radioligand. His Pharmacology study incorporates themes from Dopamine receptor, Inverse agonist and Apomorphine. His Dopamine research is covered under the topics of Endocrinology and Internal medicine.

Between 2003 and 2021, his most popular works were:

  • Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders (260 citations)
  • Advances in development of dopaminergic aporphinoids. (85 citations)
  • A preliminary PET evaluation of the new dopamine D2 receptor agonist [11C]MNPA in cynomolgus monkey (80 citations)

In his most recent research, the most cited papers focused on:

  • Organic chemistry
  • Dopamine
  • Biochemistry

His scientific interests lie mostly in Stereochemistry, Agonist, Receptor, Pharmacology and Opioid. His Stereochemistry research includes themes of Opioid receptor, Chemical synthesis and Ligand. The various areas that John L. Neumeyer examines in his Agonist study include Pharmacophore, Dopamine receptor D2 and Structure–activity relationship.

His work in Receptor is not limited to one particular discipline; it also encompasses Dopamine. He has included themes like Biochemistry, Tropane and Serotonin in his Dopamine study. His studies deal with areas such as Morphine and Antagonist as well as Opioid.

Best Publications

  • SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.

    Marc Laruelle;Ronald M. Baldwin;Robert T. Malison;Yolanda Zea-Ponce

  • Cocaine receptors labeled by [3H]2 beta-carbomethoxy-3 beta-(4-fluorophenyl)tropane.

    B K Madras;R D Spealman;M A Fahey;J L Neumeyer

  • Graphical, Kinetic, and Equilibrium Analyses of in vivo [123I]β-CIT Binding to Dopamine Transporters in Healthy Human Subjects

    Marc Laruelle;Elizabeth Wallace;John P. Seibyl;Ronald M. Baldwin

  • Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders

    Na Ye;John L. Neumeyer;Ross J. Baldessarini;Xuechu Zhen

  • [123I]-2 beta-carbomethoxy-3 beta-(4-iodophenyl)tropane: high-affinity SPECT radiotracer of monoamine reuptake sites in brain.

    Neumeyer Jl;Wang Sy;Milius Ra;Baldwin Rm

  • N-omega-fluoroalkyl analogs of (1R)-2 beta-carbomethoxy-3 beta-(4-iodophenyl)-tropane (beta-CIT): radiotracers for positron emission tomography and single photon emission computed tomography imaging of dopamine transporters.

    J. L. Neumeyer;S. Wang;Yigong Gao;R. A. Milius

  • In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.

    Dean F. Wong;Babington Yung;Robert F. Dannals;Elias K. Shaya;Elias K. Shaya

  • Comparative nigrostriatal dopaminergic imaging with iodine-123-beta CIT-FP/SPECT and fluorine-18-FDOPA/PET.

    Tatsuya Ishikawa;Vijay Dhawan;Ken Kazumata;Thomas Chaly

  • Dopamine Transporter Imaging with Fluorine-18-FPCIT and PET

    Ken Kazumata;Vijay Dhawan;Thomas Chaly;Angelo Antonini

  • Single photon emission computed tomography imaging of monoamine reuptake sites in primate brain with [123I]CIT.

    Robert Innis;Ronald Baldwin;Elzbieta Sybirska;Yolanda Zea

  • Dopamine D2 receptor binding sites for agonists. A tetrahedral model.

    P Seeman;M Watanabe;D Grigoriadis;J L Tedesco

  • SPECT Imaging of Dopamine Transporters in Human Brain with Iodine-123-Fluoroalkyl Analogs of β-CIT

    Anissa Abi-Dargham;Mitchell S. Gandelman;Gabriel A. DeErausquin;Yolanda Zea-Ponce

  • Differences in the nature of the stereotyped behaviour induced by aporphine derivatives in the rat and in their actions in extrapyramidal and mesolimbic brain areas.

    Brenda Costall;Robert J. Naylor;John L. Neumeyer

  • Advances in development of dopaminergic aporphinoids.

    Ao Zhang;Yi Zhang;Alan R Branfman;Ross J Baldessarini

  • Receptor affinities of dopamine D1 receptor-selective novel phenylbenzazepines.

    John L Neumeyer;Nora S Kula;Jack Bergman;Ross J Baldessarini

  • [11C]β-CIT, a cocaine analogue. Preparation, autoradiography and preliminary PET investigations

    Lars Müller;Christer Halldin;Lars Farde;Per Karlsson

  • The Sigma-RBI handbook of receptor classification and signal transduction

    Keith J. Watling;J. W. Kebabian;John L. Neumeyer

  • Design and synthesis of novel dimeric morphinan ligands for kappa and micro opioid receptors.

    John L. Neumeyer;Ao Zhang;Wennan Xiong;Xiao-Hui Gu

  • N-Substituted Analogs of 2β-Carbomethoxy-3β-(4‘-iodophenyl)tropane (β-CIT) with Selective Affinity to Dopamine or Serotonin Transporters in Rat Forebrain

    John L. Neumeyer;Gilles Tamagnan;Shaoyin Wang;Yigong Gao

  • Radiosynthesis of [18F] N-3-fluoropropyl-2-β-carbomethoxy-3-β-(4-iodophenyl) nortropane and the first human study with positron emission tomography

    Thomas Chaly;Vijay Dhawan;Ken Kazumata;Angelo Antonini

  • Recent Progress in Development for Dopamine Receptor Subtype-Selective Agents: Potential Therapeutics for Neurological and Psychiatric Disorders

    Ao Zhang;John L. Neumeyer;Ross J. Baldessarini

Frequent Co-Authors

Ross J. Baldessarini
Ross J. Baldessarini Harvard University
Jean M. Bidlack
Jean M. Bidlack University of Rochester
Robert B. Innis
Robert B. Innis National Institutes of Health
Dennis S. Charney
Dennis S. Charney Icahn School of Medicine at Mount Sinai
Philip Seeman
Philip Seeman University of Toronto
Gilles Tamagnan
Gilles Tamagnan Yale University
Hyman B. Niznik
Hyman B. Niznik University of Toronto
Frank I. Tarazi
Frank I. Tarazi Harvard University
Paul Vouros
Paul Vouros Northeastern University
Bertha K. Madras
Bertha K. Madras Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, especially with an eye toward forensic applications, exploring related degrees can broaden career opportunities. One promising pathway is pursuing a masters in forensic psychology online, which blends chemical knowledge with psychological principles in criminal investigations.

Career options extend beyond traditional labs. Those with chemistry backgrounds can explore various forensic careers, where analytical skills are crucial to solving crimes. Positions often require a firm grasp of both scientific methods and law enforcement protocols.

Considering cost is essential before committing to any degree program. Resources that detail how much does it cost to get a criminal justice degree can help prospective students budget effectively and find affordable education options aligned with their goals.

For those starting their journey, the best online criminal justice associate degree programs offer accessible entry points. These programs often complement a chemistry foundation, preparing graduates for technical roles in enforcement and forensic labs.

Best Scientists Citing John L. Neumeyer

Trending Scientists

Recently Published Articles